This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Imprimis Pharmaceuticals Inc (IMMY)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 8.21M 15.58M 10.04M 146.16K
Receivables 81.32K 0.00 0.00 0.00
Inventories 372.74K 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 9.06M 15.73M 10.69M 160.96K
Property, Plant & Equipment, Gross 288.83K 26.89K 15.49K 0.00
Accumulated Depreciation & Depletion 45.44K 0.00 2.94K 0.00
Property, Plant & Equipment, Net 243.40K 26.89K 12.55K 0.00
Intangibles 610.99K 0.00 0.00 0.00
Other Non-Current Assets 0.00 0.00 0.00 0.00
Total Non-Current Assets 1.19M 26.89K 12.55K 0.00
Liabilities & Shareholder Equity
Total Assets 10.24M 15.76M 10.71M 160.96K
Accounts Payable 786.68K 261.92K 286.69K 274.70K
Short Term Debt 24.11K 0.00 0.00 300.00K
Other Current Liabilities 31.47K 0.00 2.48K 0.00
Total Current Liabilities 1.56M 650.63K 709.56K 1.86M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 512.81K 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 531.78K 0.00 0.00 0.00
Total Liabilities 2.09M 650.63K 709.56K 1.86M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 8.15M 15.11M 10.00M -1.70M
Common Par 9.26K 8.97K 6.77K 15.90K
Additional Paid In Capital 50.01M 46.85M 34.09M 16.80M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -41.87M -31.75M -24.10M -18.52M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 8.15M 15.11M 10.00M -1.70M
Total Equity 8.15M 15.11M 10.00M -1.70M
Total Liabilities & Stock Equity 10.24M 15.76M 10.71M 160.96K
Total Common Shares Outstanding 9.26M 8.97M 6.77M 397.52K
Preferred Shares 0.00 0.00 10.00 10.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 9.13M 8.66M 4.49M 397.80K
Diluted Weighted Shares Outstanding 9.13M 8.66M 4.49M 397.80K
Number of Employees 56 17 4 2
Number of Part-Time Employees 8 0 1 1

IMMY Imprimis Pharmaceuticals Inc

Chart of IMMY

Analysts Ratings for IMMY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

IMMY Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs